Here, we characterized the antitumor activity of anti-TGF-β CAR T cells and found that their CD4+ but not CD8+ compartment induced the death of cancer cells in vitro and robustly suppressed the growth of various tumor models. This evidence concerns the gene TGFB1 and neoplasm.